CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 3 Randomized, Placebo-Controlled, Double-Masked, Multicenter, Safety and Efficacy Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03591874
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:35.520564+00:00
- Published At
- 2022-07-06T00:00:00+00:00
- Record Updated At
- 2022-07-06
- Results Posted At
- 2022-07-06
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Graft Versus Host Disease", "Ocular Surface Disease", "oGVHD", "Ocular Graft vs Host Disease", "Brimonidine Tartrate", "Lubricant Eye Drops", "Ophthalmic Solutions", "Graft vs Host Disease"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-07-06"- protocolSection.identificationModule.nctId
"NCT03591874"- protocolSection.identificationModule.officialTitle
"A Phase 3 Randomized, Placebo-Controlled, Double-Masked, Multicenter, Safety and Efficacy Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2022-07-06"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.